Psychedelic BioTech Company Treats Gambling Disorder with Ketamine

Awakn Life Sciences Corp. , a psychedelic biotechnology company focused on researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder, has announced on June 2nd that they have initiated a larger behavioral addiction study investigating ketamine as a treatment for Gambling Disorder.